alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
FILED

United States Court of Appeals

Tenth Circuit

February 3, 2010

Elisabeth A. Shumaker

Clerk of Court

UNITED STATES COURT OF APPEALS

TENTH CIRCUIT

LARRY ALLEN CHIEFLY,

Petitioner - Appellant, No. 09-6215

v. (W.D. Oklahoma)

WARDEN PROVINCE,

Respondent - Appellee.

(D.C. No. 5:09-CV-00147-M)

ORDER DENYING CERTIFICATE OF APPEALABILITY

Before HARTZ, ANDERSON, and TYMKOVICH, Circuit Judges.

Larry Chiefly seeks a certificate of appealability (COA) to appeal the

denial of his application under 28 U.S.C. § 2254. See 28 U.S.C. § 2253(c)(1)(A)

(requiring COA to appeal denial of § 2254 application). The United States

District Court for the Western District of Oklahoma denied the application on the

ground that it was untimely. See id. § 2244(d). We deny the application for a

COA and dismiss the appeal.

A COA will issue “only if the applicant has made a substantial showing of

the denial of a constitutional right.” Id. § 2253(c)(2). This standard requires “a

demonstration that . . . includes showing that reasonable jurists could debate

whether (or, for that matter, agree that) the petition should have been resolved in

a different manner or that the issues presented were adequate to deserve
-2-

encouragement to proceed further.” Slack v. McDaniel, 529 U.S. 473, 484 (2000)

(internal quotation marks omitted). In other words, an applicant must show that

the district court’s resolution of the constitutional claim was either “debatable or

wrong.” Id. If the application was denied on procedural grounds, the applicant

faces a double hurdle. Not only must the applicant make a substantial showing of

the denial of a constitutional right, but he must also show “that jurists of reason

would find it debatable . . . whether the district court was correct in its procedural

ruling.” Id. “Where a plain procedural bar is present and the district court is

correct to invoke it to dispose of the case, a reasonable jurist could not conclude

either that the district court erred in dismissing the petition or that the petitioner

should be allowed to proceed further.” Id.

In this case no reasonable jurist could debate the correctness of the district

court’s determination that Mr. Chiefly’s application under § 2254 was untimely,

as explained in the excellent report and recommendation by the magistrate judge. 

Indeed, in his brief before this court, Mr. Chiefly does not dispute that § 2244(d)

bars his claim. Rather, he challenges the constitutionality of that statutory

provision, at least as applied to his claim. But he did not raise that constitutional

challenge in district court; so it is not properly before us. See Hammon v. Ward,

466 F.3d 919, 926 n.8 (10th Cir. 2006).
-3-

Accordingly, we DENY Mr. Chiefly’s application for a COA and DISMISS

the appeal.

ENTERED FOR THE COURT

Harris L Hartz

Circuit Judge
---

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO RULE 13a-14(A)/15d-14(A) OF
  THE 
  SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED
  PURSUANT TO SECTION 302 AND 906 OF THE SARBANES-OXLEY ACT OF 2003**

I, Jim Fischbach, Chief Executive Officer of Intrepid Global
  Imaging 3D Inc. certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Intrepid
  Global Imaging 3D Inc;

2. Based on my knowledge, this quarterly report does not contain
  any untrue statement of a material fact or omit to state a material fact necessary
  to make the statements made, in light of the circumstances under which such
  statements were made, not misleading with respect to the period covered by this
  quarterly report;

3. Based on my knowledge, the financial statements, and other
  financial information included in this quarterly report, fairly present in all
  material respects the financial condition, results of operations and cash flows
  of the registrant as of, and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining disclosure
  controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)
  for the registrant and have:

a) Designed such disclosure controls and procedures to ensure
  that material information relating to the registrant, including its consolidated
  subsidiaries, is made known to me by others within those entities, particularly
  during the period in which this quarterly report is being prepared; b) Evaluated
  the effectiveness of the registrant's disclosure controls and procedures as
  of a date within 90 days prior to the filing date of this quarterly report (the
  "Evaluation Date"); and c) Presented in this quarterly report my conclusions
  about the effectiveness of the disclosure controls and procedures based on my
  evaluation as of the Evaluation Date;

5. I have disclosed, based on my most recent evaluation, to the
  registrant's auditors and the audit committee of registrant's board of directors
  (or persons performing the equivalent functions): a) All significant deficiencies
  in the design or operation of internal controls which could adversely affect
  the registrant's ability to record, process, summarize and report financial
  data and have identified for the registrant's auditors any material weaknesses
  in internal controls; and b) Any fraud, whether or not material, that involves
  management or other employees who have a significant role in the registrant's
  internal controls; and

6. I have indicated in this quarterly report whether or not there
  were significant changes in internal controls or in other factors that could
  significantly affect internal controls subsequent to the date of my most recent
  evaluation, including any corrective actions with regard to significant deficiencies
  and material weaknesses.

/s/ Jim Fischbach
  By: Jim Fischbach, Chief Executive Officer

May 17, 2007

---
No. 11-5280.

#### George Wortham, Petitioner v. Chris Hansen Lab Incorporated.

565 U.S. 899, 132 S. Ct. 291,

181 L. Ed. 2d 176,

2011 U.S. LEXIS 5513.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
No. 10-10912.

#### Beverly Ann Blake, Petitioner v. Warren Maley.

565 U.S. 856, 132 S. Ct. 189,

181 L. Ed. 2d 97,

2011 U.S. LEXIS 6287,

October 3, 2011.

Petition for writ of certiorari to the Court of Appeal of Louisiana, Second Circuit, denied.

Same case below, 57 So. 3d 1122.
No. 10-1285.

#### Countrywide Home Loans, Inc., Petitioner v. Francisco Rodriguez, et ux.

565 U.S. 1034, 132 S. Ct. 573,

181 L. Ed. 2d 420,

2011 U.S. LEXIS 8261.

November 14, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

Same case below, 629 F.3d 136.
No. 11-5106.

#### Andre Jones, Petitioner v. Camden Police Department, et al.

565 U.S. 890, 132 S. Ct. 269,

181 L. Ed. 2d 158,

2011 U.S. LEXIS 5312.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 417 Fed. Appx. 351.
No. 11-468.

#### L. L. Benas, Petitioner v. Leroy Baca, et al.

565 U.S. 1062, 132 S. Ct. 782,

181 L. Ed. 2d 488,

2011 U.S. LEXIS 8644.

November 28, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 433 Fed. Appx. 524.
No. 11-6305.

#### Paul Branch, Petitioner v. United States.

565 U.S. 958, 132 S. Ct. 440,

181 L. Ed. 2d 286,

2011 U.S. LEXIS 7201.

October 11, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.

Same case below, 421 Fed. Appx. 659.
First Union National Bank
                               Commercial Banking
                                     CT2006
                                 300 Main Street
                               Stamford, CT 06901

March 18, 2002


Mr. Walter Lazarcheck
Chief Financial Officer
Farrel Corporation
Ansonia, CT

     Re: Letter  agreement to modify  definition of  "Consolidated  Adjusted Net
     Worth"  contained in the text of Section 7.3 of the Revolving and Term Loan
     Credit Agreement dated as of June 18, 2001 ("the Agreement"), between First
     Union National Bank  ("Bank");  and Farrel  Corporation  and Farrel Limited
     (individually and collectively, "Borrower").

Dear Walter:

Per previous  discussions  between  Bank and  Borrower,  Bank hereby  agrees the
definition  of  "Consolidated  Adjusted Net Worth",  as it is shown in the third
sentence of Section 7.3 of the Agreement, will now read as follows:

     Consolidated   Adjusted  Net  Worth  means   Borrower's   consolidated
     stockholders'  equity,  in accordance with GAAP,  exclusive of (i) any
     amount  arising  from  the  cumulative  foreign  currency  translation
     adjustment   reported  in   Borrower's   consolidated   statement   of
     stockholders'  equity,  and (ii) an amount arising from the cumulative
     minimum  pension   liability   reported  in  Borrower's   consolidated
     statement of  stockholders'  equity not to exceed  $3,500,000 when the
     Consolidated  Adjusted  Net Worth is tested as of December  31,  2001,
     March 31, 2002,  June 2002 and September  30, 2002,  and not to exceed
     $2,500,000  when the  Consolidated  Adjusted Net Worth is tested as of
     December 31, 2002 and each test date thereafter.

First  Union also  agrees the  aforementioned  new  definition  of  Consolidated
Adjusted Net Worth is effective as of the December 31, 2001 test date.

This letter  agreement  applies to the definition of  Consolidated  Adjusted Net
Worth only.  This letter does not amend any other term,  condition or definition
contained in the Agreement.  Please sign below to indicate your agreement to the
aforementioned modification and return one signed copy of this letter to me.

Sincerely,

/s/ Anne Wilson
-------------------------
Anne Wilson
Vice President

Borrower hereby agrees to the modification referenced in this letter.

/s/ Walter Lazarcheck
-------------------------
Walter Lazarcheck
Chief Financial Officer
Farrel Corporation
[Federal Register Volume 63, Number 141 (Thursday, July 23, 1998)]
[Presidential Documents]
[Page 39695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19917]


      

[[Page 39693]]

_______________________________________________________________________

Part V





The President





_______________________________________________________________________



Presidential Determination No. 98-33 of July 15, 1998--Presidential 
Determination on the Proposed Agreement for Cooperation Between the 
Government of the United States of America and the Government of 
Romania Concerning Peaceful Uses of Nuclear Energy


                        Presidential Documents 



Federal Register / Vol. 63, No. 141 / Thursday, July 23, 1998 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 39695]]

                Presidential Determination No. 98-33 of July 15, 1998

                
Presidential Determination on the Proposed 
                Agreement for Cooperation Between the Government of the 
                United States of America and the Government of Romania 
                Concerning Peaceful Uses of Nuclear Energy

                Memorandum for the Secretary of State, [and] the 
                Secretary of Energy

                I have considered the proposed Agreement for 
                Cooperation Between the Government of the United States 
                of America and the Government of Romania Concerning 
                Peaceful Uses of Nuclear Energy, along with the views, 
                recommendations, and statements of the interested 
                agencies.

                I have determined that the performance of the agreement 
                will promote, and will not constitute an unreasonable 
                risk to, the common defense and security. Pursuant to 
                section 123b. of the Atomic Energy Act of 1954, as 
                amended (42 U.S.C. 2153(b)), I hereby approve the 
                proposed agreement and authorize you to arrange for its 
                execution.

                The Secretary of State is authorized and directed to 
                publish this determination in the Federal Register.

                    (Presidential Sig.)<Clinton1><Clinton2>

                THE WHITE HOUSE,

                    Washington, July 15, 1998.

[FR Doc. 98-19917
Filed 7-22-98; 8:45 am]
Billing code 4710-10-M
No. 10-1491.

#### Esther Kiobel, Individually and on Behalf of Her Late Husband, Dr. Barinem Kiobel, et al., Petitioners v. Royal Dutch Petroleum Co., et al.

565 U.S. 961, 132 S. Ct. 472,

181 L. Ed. 2d 292,

2011 U.S. LEXIS 7522.

October 17, 2011.

Motion of International Law Scholars for leave to file a brief as amici curiae granted. Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit granted, and case is to be argued in tandem with No. 11-88, Mohamad, Individually and for the Estate of Rahim, Deceased, et al. v. Palestinian Authority, et al., infra.

Same case below, 621 F.3d 111.
----

----

| 1. | the      quarterly report on Form 10-QSB of Falcon Ridge Development Inc., for the      period ended June 30, 2008 (the “Report”) fully complies with the      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of      1934; and |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | the      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of Falcon      Ridge Development Inc.,. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                             |                         |                          |
|----------------------------------|------------------------------|-------------------------------|
|                             |                         |
|                             |                         |                          |
| Dated: August      13, 2008 |                         | /s/ Fred      M. Montano |
|                             | Fred      M. Montano,        |
|                             | Chief      Executive Officer |

----

----
No. 10-10961.

#### Yusuf A. Shabazz, Petitioner v. Thalrone Williams, Warden.

565 U.S. 859, 132 S. Ct. 195,

181 L. Ed. 2d 102,

2011 U.S. LEXIS 6149.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from
Morgan Stanley Dean Witter Charter Millburn L.P. and is qualified
in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                  6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      24,026,878
<SECURITIES>                                         0
<RECEIVABLES>                                  704,255<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              24,297,902<F2>
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                24,297,902<F3>
<SALES>                                              0
<TOTAL-REVENUES>                           (1,691,456)<F4>
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,094,390
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,785,846)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,785,846)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,785,846)
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1>Receivables include subscriptions receivable of $591,573 and
interest receivable of $112,682.
<F2>In addition to cash and receivables, total assets include net
unrealized loss on open contracts of $433,231.
<F3>Liabilities include redemptions payable of $362,537, accrued
brokerage fees of $143,988 and accrued management fees of $41,139.
<F4>Total revenues include realized trading revenue of $(982,883), net
change in unrealized of $(1,354,054) and interest income of $645,481.
</FN>



</TABLE>
Privacy Reminders

14. Disposing of Paper Records Containing PII

How to Dispose of Paper Records Containing Personal Information / PII: Paper 

records containing PII must be disposed of in a manner that renders the information 

unrecognizable or beyond reconstruction. Two acceptable methods for disposing of paper 

records containing PII are using a cross-cut shredder or placing the paper(s) in a burn bag. 

Do not use a recycle bin to dispose of paper records containing personal information / 

PII. 

Do not leave files with PII behind when moving from one office to another. 

Always destroy records in accordance with the DLA Records Schedule. 

For more information, contact your local Privacy Officer or your local OPSEC Officer.

<Return to Reminders Table>
Tolerance ID Descriptor L* a* b* c h dL* da* db* dEcmc*

DESERT 

TAN 511 STANDARD 60.47 5.77 9.80

URBAN 

TAN 512 STANDARD 51.21 5.55 10.71

LIGHT 

BROWN 

513

STANDARD 41.48 6.70 15.91

DARK 

BROWN 

514

STANDARD 33.88 6.88 13.42

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Shade Number NWU II DESERT Piece/Roll Number 19116

DLA/NAVY SHADE TOLERANCE PROJECT October 5, 2019

Fabric Nomenclature CLOTH, RIPSTOP, NYLON AND COTTON 

BLEND, CAMOUFLAGE NCTRF PD 05-11
Exhibit 32.2

CERTIFICATION

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), the undersigned officer of Heidrick & Struggles International, Inc., a Delaware corporation (the Company), does hereby certify that:

The Quarterly Report on Form 10-Q for the quarter ended June 30, 2009 (the Form 10-Q) of the Company fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                      |  |                                                   
|--------------------- |  | --------------------------------------------------
|Dated: August 3, 2009 |  | /s/ Scott J. Krenz                                
|                      |  | Scott J. Krenz                                    
|                      |  | Executive Vice President & Chief Financial Officer
Final - February 4, 2022

Dr. Grace Lee (ACIP Chair)

Dr. Melinda Wharton (ACIP Executive Secretary, CDC)

10:15 Coronavirus Disease 2019 (COVID-19) Vaccines

Introduction

mRNA 1273 COVID-19 vaccine BLA safety and efficacy data

Dr. Matthew Daley (ACIP, WG Chair)

Dr. Rituparna Das (Moderna)

11:00 Break

11:10 Public Comment

11:45 Updates on myocarditis and pericarditis following Moderna 

COVID-19 vaccination 

Update on myocarditis outcomes: MOVING

VaST assessment

Dr. Tom Shimabukuro (CDC/NCEZID)

Dr. Ian Kracalic (CDC/NCEZID)

Dr. Keipp Talbot (ACIP, VaST Chair)

12:30 Break

1:00 GRADE: Moderna COVID-19 vaccine

EtR Framework: Moderna COVID-19 vaccine primary series in 

adults ≥18 years of age

Discussion

VOTE 

Moderna COVID-19 vaccine for individuals ≥18 years of age 

Dr. Megan Wallace (CDC/NCIRD)

Dr. Sara Oliver (CDC/NCIRD)

Dr. Sara Oliver (CDC/NCIRD)

2:30 Break

Updates to Clinical Considerations

Canadian experience and evidence with COVID-19 vaccine 

primary series extended intervals

VSD: Myocarditis after Moderna and Pfizer/BioNTech COVID-19 

vaccine

Myocarditis and COVID-19 vaccine intervals: International data 

and policies

Summary and Work Group Interpretation: Extended intervals for

mRNA COVID-19 vaccines

Discussion

Dr. Elisha Hall (CDC/NCIRD)

Dr. Matthew Tunis (Public Health Agency of Canada), Dr. Bryna 

Warshawsky (Public Health Agency of Canada), Ms. Susanna 

Ogunnaike-Cooke (Public Health Agency of Canada)

Dr. Nicky Klein (KPNC)

Ms. Danielle Moulia (CDC/NCIRD)

Dr. Sara Oliver (CDC/NCIRD)

5:00 Adjourn

Acronyms

CDC

CMS Centers for Medicare and Medicaid Services 

COVID-19 Coronavirus disease 2019

EtR Evidence to Recommendations Framework

FDA Food and Drug Administration

GRADE

HRSA Health Resources and Services Administration

IHS Indian Health Service

NCHHSTP

NCIRD

NCEZID

NIAID

OIDP Office of Infectious Disease and HIV/AIDS Policy

SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2

WG Work Group

WHO World Health Organization

VE Vaccine Effectiveness

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

Centers for Disease Control and Prevention

Atlanta, Georgia 30329 

February 4, 2021

Friday, February 4, 2022

10:00 Welcome & Introductions

National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Grading of Recommendations Assessment, Development and Evaluation

National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID] 

National Center for Immunization & Respiratory Diseases [of CDC/OID] 

National Center for Emerging and Zoonotic Diseases [of CDC/OID]
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

**COMMONWEALTH OF PENNSYLVANIA,**

**Respondent**

**v.**

**PHILIP BURNETT,**

**Petitioner :** 

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**:**

**: No. 235 EAL 2015** 

**Petition for Allowance of Appeal from the Order of the Superior Court** 

ORDER

PER CURIAM

AND NOW **, this 7th day of October, 2015, the Petition for All owance of Appeal is** 

DENIED

**.**
No. 11-6432.

#### Calvin Carlos Campbell, Petitioner v. Florida.

565 U.S. 1017, 132 S. Ct. 557,

181 L. Ed. 2d 402,

2011 U.S. LEXIS 8064.

November 7, 2011.

Petition for writ of certiorari to the District Court of Appeal of Florida, First District, denied.

Same case below, 65 So. 3d 1056.